<table><tr><td>Doc.No:</td></tr><tr><td>100-005-DVP-001</td></tr><tr><td>Issued by:</td></tr><tr><td>Zoey</td></tr></table>

<table><tr><td>version:</td></tr><tr><td>1.0</td></tr><tr><td>effective date:</td></tr></table>

# Design Verification and Validation Master Plan

<table><tr><td colspan="2">Project Name:</td><td colspan="6">Simject-030 Adrenaline (Adult) Project by LBE Pharma</td></tr><tr><td colspan="2">Project Code:</td><td colspan="2">SM100-005</td><td colspan="2">Product</td><td colspan="2">AISI104</td></tr><tr><td colspan="2">Project Manager</td><td colspan="2">Linda.He</td><td colspan="2">R&amp;D Engineer</td><td colspan="2">Logan</td></tr><tr><td colspan="2">Doc Number:</td><td colspan="2">100-005-DVP-001</td><td colspan="2">Date:</td><td colspan="2"></td></tr><tr><td colspan="8">Review Record</td></tr><tr><td>Drafter</td><td>RD</td><td>Zoey</td><td colspan="2"></td><td colspan="2">Date</td><td></td></tr><tr><td></td><td>RD</td><td>Logan</td><td colspan="2"></td><td colspan="2">Date</td><td></td></tr><tr><td></td><td>RA</td><td>Grace</td><td colspan="2"></td><td colspan="2">Date</td><td></td></tr><tr><td>Approver</td><td>RD</td><td>Kevin</td><td colspan="2"></td><td colspan="2">Date</td><td></td></tr></table>

<table><tr><td colspan="5">Revision History</td></tr><tr><td>Version</td><td>Revision Date</td><td>Editor</td><td>Page</td><td>Revision content</td></tr><tr><td>1.0</td><td>2025.11.27</td><td>Zoey</td><td>/</td><td>new version</td></tr><tr><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td></tr></table>

<table><tr><td>Doc.No: 
100-005-DVP-001</td><td>version: 
1.0</td></tr><tr><td>Issued by: 
Zoey</td><td>effective date:</td></tr></table>

# 1. Contents

1. Contents 2

2. Purpose 3

3. Responsibilities.. 3

4. Project Team 4

5. Tracking And Reporting Systems 4

6.Definitions. 4

7. Contents 5

7.1.Product Overview.. 5

7.2.Intended Use 5

7.3. Assembly Process Description 5

8. Testing Facility.. 6

9. Relevant Standards/Regulations/References 6

10. Configuration 9

10.1. Component list.. 9

10.2. Package parts.. 9

10.3. Accessory list.. 9

10.4. Equipment Qualification 10

11. Design Verification/Validation 10

11.1. Tools verification/Validation 10

11.2. Process/Testing Equipment/Machine Verification/Validation 11

11.3. Verification/validation Test Matrix 13

11.4. Design Verification/Validation Test Executive Summary 14

12. Schedule And Resources 17

13. V/VMP Plan Review 17

# 2. Purpose

The purpose of this Design Verification and Validation Master Plan (V/VMP) is to document the required tests for a formal product related project. This plan lists which tests shall be conducted by SUMMED for design, process and user V/V, as required by the FDA Quality System Regulation (21 CFR 820) and ISO13485:2016. This V/VMP is designed for the medical device constituent of a combination product.

The Verification and Validation activities are driven from input approved at Design Review

$\diamond$  The Design Input Requirement (DIR), document no. 5df3c61b-73b1-4321-ad5a-24b2f261329d.docx which provides the acceptance criteria and which tests that shall be conducted to meet the DIR.

$\spadesuit$  The User Requirement Specification (URS), document no. 100-005-URS-001(2.0).

$\diamond$  Product Requirement Specification document no. 5df3c61b-73b1-4321-ad5a-24b2f261329d.docx(1.0), Regulatory requirements and Standards are the basis for the DIR.

$\diamond$  Risk Assessment for Management plan, document no. 5df3c61b-73b1-4321-ad5a-24b2f261329d.docx, and FMEA in which D-FMEA document no. 5df3c61b-73b1-4321-ad5a-24b2f261329d.docx2.0), P-FMEA document no. 5df3c61b-73b1-4321-ad5a-24b2f261329d.docx1.0), where the risk mitigation and tests are being described.

# 3. Responsibilities

3.1 The Project Leader: responsible for modifying this plan to include all required tests for the device that requires V/V.

3.2 Validation Manager: responsible for reviewing the test data and the report. Coordinate with test team analysts for validation test.

3.3 Validation Analyst: responsible for supporting/performing the test of the samples

3.4 R&D Engineer : responsible for reviewing the master plan

3.5 R&D Manager : responsible for approving the master plan and the protocol

3.6 PD Production team: responsible for arranging the production plan and preparing the validation samples.

<table><tr><td>Doc.No: 
100-005-DVP-001</td><td>version: 
1.0</td></tr><tr><td>Issued by: 
Zoey</td><td>effective date:</td></tr></table>

And responsible for installation, set-up, and operation of manufacturing equipment for validation.

3.7 RA team: responsible for Supporting the validation process in meeting applicable regulatory standards.

3.8 QC team: responsible for installation, set-up, and equipment acceptance of testing equipment for validation.

3.9 QA manager: responsible for reviewing the verification activities to ensure they meet the system requirements

# 4. Project Team

The goal of this document is to clearly describe the overall V/VMP plan so that any Summed function required to take on a test role can easily identify and contact the personnel involved in the project. Note that there may be several people in each role, or one person may be obliged to fill multiple roles.

<table><tr><td>Role</td><td>Name</td><td>SUMMED Function</td></tr><tr><td>Project Leader</td><td>Linda.He</td><td>PM</td></tr><tr><td>Validation Manager</td><td>Linda.Wang</td><td>RD</td></tr><tr><td>Test Designer</td><td>Linda.Wang</td><td>RD</td></tr><tr><td>Test Personnel</td><td>Zoey</td><td>RD</td></tr><tr><td>QA Representative</td><td>Zen Yang</td><td>QA</td></tr><tr><td>Documentation Reviewers</td><td>Grace、Alex、Kevin</td><td>RD、RA、BD</td></tr><tr><td>Regulatory Reviewers</td><td>Grace</td><td>RA</td></tr></table>

# 5. Tracking And Reporting Systems

If there is a test failure, an investigation shall be conducted and documented as part of the test report. Justification must be provided in the test report if the results are still considered valid. If the results of the investigation lead to a change in design, Document and Change Controls, document no.QP01 and QW-RD-03 shall be followed for documentation and traceability purposes, and the Project Team shall be notified of the change so that affected areas maybe properly handled.

# 6. Definitions

- Design Validation means establishing by objective evidence that device specifications conform to user needs and intended use(s). Design validation shall be performed under defined operating conditions (under actual or simulated use conditions) on initial production units, lots, or batches, or their equivalents.

- Design Verification means establishing by objective evidence confirming that the design output (i.e., specifications and procedures for the designed device, requirements for packaging, and labeling) meets the design input requirements. Design verification involves reviewing, inspecting, testing, checking, auditing or otherwise establishing whether or not components, subsystems, systems, and the final device designed meet the requirements of design inputs.

- Process Validation indicates that a process has been subject to such testing and analysis that the result of the process (a product, a service or other outcome) can be practically guaranteed. Validation of a process entails demonstrating that, when a process is operated within specified limits, it will consistently produce product complying with predetermined (design and development) requirements.

- Tool/Equipment Validation is the process of checking that a tool or equipment meets specifications and that it fulfills its intended purpose and it will consistently produce product complying with predetermined (design and development) requirements.

# 7. Contents

# 7.1. Product Overview

Refer to 1ml PFS specification, document no.100-005-URS-001(2.0)

Refer to Design Input Requirements, document no. 5df3c61b-73b1-4321-ad5a-24b2f261329d.docx

# 7.2. Intended Use

Simject Auto-Injector is intended for use with epinephrine (pre-filled  $0.3\mathrm{mL}$ ,  $0.30\mathrm{mg}/0.3\mathrm{mL}$ ) for

medication delivery (intramuscular injection). For single-patient use only.

# 7.3. Assembly Process Description

Front assembly refer to Assembly Flow Chart, document no. 5df3c61b-73b1-4321-ad5a-

24b2f261329d.docx

Rear assembly flow chart refer to the document: QW-PD-08 (A/1)

# 8. Testing Facility

The tests listed in this V/VMP will be conducted at SUMMED, located in Jia-Shan, China.

# 9. Relevant Standards/Regulations/References

The medical device will be tested using methods listed in relevant standard/regulations, such as but not limited to the following: Free fall testing method


Standards/Regulations Reference


<table><tr><td>Standard Classification</td><td>No.</td><td>Standard</td><td>Description</td></tr><tr><td rowspan="4">China</td><td>1.</td><td>GB/T42061-2022</td><td>医疗器械质量管理体系用于法规的要求</td></tr><tr><td>2.</td><td>GB/T42062-2022</td><td>医疗器械风险管理对医疗器械的应用</td></tr><tr><td>3.</td><td>YY/T1437-2023</td><td>医疗器械GB/T 42062应用指南</td></tr><tr><td>4.</td><td>YY/T 0681.15-2019</td><td>无菌医疗器械包装试验方法 第15部分：运输容器和系统的性能试验</td></tr></table>

<table><tr><td>Doc.No: 
100-005-DVP-001</td><td>version: 
1.0</td></tr><tr><td>Issued by: 
Zoey</td><td>effective date:</td></tr></table>

<table><tr><td rowspan="10"></td><td>5.</td><td>YY/T 1474-2016</td><td>医疗器械可用性工程对医疗器械的应用</td></tr><tr><td>6.</td><td>YY/T 0681.1-2018</td><td>无菌医疗器械包装试验方法 第1部分:加速老化试验指南</td></tr><tr><td>7.</td><td>YY/T 1768.1-2021</td><td>医用针式注射系统 要求和试验方法 第1部分:针式注射系统</td></tr><tr><td>8.</td><td>GB/T16886.1-2022</td><td>医疗器械生物学评价 第1部分:风险管理过程中的评价与试验</td></tr><tr><td>9.</td><td>GB/T16886.5-2017</td><td>医疗器械生物学评价 第5部分:体外细胞毒性试验</td></tr><tr><td>10.</td><td>GB/T16886.10-2017</td><td>医疗器械生物学评价 第10部分:刺激与皮肤致敏试验</td></tr><tr><td>11.</td><td>GB/T 16886.23-2023</td><td>医疗器械生物学评价 第23部分:刺激试验</td></tr><tr><td>12.</td><td>GB/T16886.18-2022</td><td>医疗器械生物学评价 第18部分:风险管理过程中医疗器械材料的化学表征</td></tr><tr><td>13.</td><td>GB/T 42063-2022</td><td>锐器伤害保护 要求与试验方法一次性使用皮下注射针、介入导管导引针和血样采集针的锐器伤害保护装置</td></tr><tr><td>14.</td><td>YY/T 0466.1.2023</td><td>医疗器械用于制造商提供信息的符号 第1部分:通用要求</td></tr><tr><td rowspan="7">International</td><td>1.</td><td>ISO13485.2016</td><td>Medical devices - Quality management systems - Requirements for regulatory purposes</td></tr><tr><td>2.</td><td>ISO 14971:2019</td><td>Medical devices - Application of risk management to medical devices</td></tr><tr><td>3.</td><td>ISO/TR 24971:2020</td><td>Medical devices - Guidance on the application of ISO 14971</td></tr><tr><td>4.</td><td>ASTM F1980:2021</td><td>Standard Guide for Accelerated Aging of Sterile Barrier Systems and Medical Devices</td></tr><tr><td>5.</td><td>IEC 62366-1:2015</td><td>Medical devices - Part 1: Application of usability engineering to medical devices</td></tr><tr><td>6.</td><td>ASTM D4169-23e1</td><td>Standard Practice for Performance Testing of Shipping Containers and Systems</td></tr><tr><td>7.</td><td>ISO 11608-1:2022</td><td>Needle-based injection systems for medical use - Requirements and test methods - Part 1: Needle-based</td></tr></table>

<table><tr><td>Doc.No: 
100-005-DVP-001</td><td>version: 
1.0</td></tr><tr><td>Issued by: 
Zoey</td><td>effective date:</td></tr></table>

<table><tr><td rowspan="9"></td><td></td><td>injection systems</td></tr><tr><td>8.</td><td>ISO 11608-5:2022Needle-based injection systems for medical use - Requirements and test methods - Part 5: Automated functions</td></tr><tr><td>9.</td><td>ISO 10993-1:2018Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process</td></tr><tr><td>10.</td><td>ISO 10993-5:2009Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity</td></tr><tr><td>11.</td><td>ISO 10993-10:2021Biological evaluation of medical devices - Part 10: Tests for skin sensitization</td></tr><tr><td>12.</td><td>ISO 10993-23:2021Biological evaluation of medical devices - Part 23: Tests for irritation</td></tr><tr><td>13.</td><td>ISO 10993-18:2020Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process</td></tr><tr><td>14.</td><td>ISO 15223-1:2021Medical devices - Symbols to be used with information to be supplied by the manufacturer - Part 1: General requirements</td></tr><tr><td>15.</td><td>ISO 23908:2024Sharps injury protection - Sharps protection mechanisms for single-use needles, introducers for catheters and needles used for blood testing, monitoring, sampling and medical substance administration - Requirements and test methods</td></tr><tr><td rowspan="8">International</td><td>1.</td><td>EN ISO 13485:2016Medical devices - Quality management systems - Requirements for regulatory purposes</td></tr><tr><td>2.</td><td>EN ISO 14971:2019Medical devices - Application of risk management to medical devices</td></tr><tr><td>3.</td><td>CEN ISO/TR 24971:2020Medical devices - Guidance on the application of ISO 14971</td></tr><tr><td>4.</td><td>ASTM F1980:2021Standard Guide for Accelerated Aging of Sterile Barrier Systems and Medical Devices</td></tr><tr><td>5.</td><td>EN IEC 62366-1:2015Medical devices - Part 1: Application of usability engineering to medical devices</td></tr><tr><td>6.</td><td>ASTM D416923e1Standard Practice for Performance Testing of Shipping Containers and Systems</td></tr><tr><td>7.</td><td>EN ISO 11608-1:2022Needle-based injection systems for medical use - Requirements and test methods - Part 1: Needle-based injection systems</td></tr><tr><td>8.</td><td>EN ISO 11608-Needle-based injection systems for medical use —</td></tr></table>

<table><tr><td>Doc.No: 
100-005-DVP-001</td><td>version: 
1.0</td></tr><tr><td>Issued by: 
Zoey</td><td>effective date:</td></tr></table>

<table><tr><td rowspan="9"></td><td></td><td>5:2022</td><td>Requirements and test methods — Part 5: Automated functions</td></tr><tr><td>9.</td><td>EN ISO 10993-1:2020</td><td>Biological evaluation of medical devices — Part 1: Evaluation and testing within a risk management process</td></tr><tr><td>10.</td><td>EN ISO 10993-5:2009</td><td>Biological evaluation of medical devices — Part 5: Tests for in vitro cytotoxicity</td></tr><tr><td>11.</td><td>EN ISO 10993-23:2021</td><td>Biological evaluation of medical devices — Part 10: Tests for skin sensitization</td></tr><tr><td>12.</td><td>EN ISO 10993-10:2023</td><td>Biological evaluation of medical devices — Part 23: Tests for irritation</td></tr><tr><td>13.</td><td>EN ISO 10993-18:2020</td><td>Biological evaluation of medical devices — Part 18: Chemical characterization of medical device materials within a risk management process</td></tr><tr><td>14.</td><td>EN ISO 15223-1:2021</td><td>Medical devices — Symbols to be used with information to be supplied by the manufacturer — Part 1: General requirements</td></tr><tr><td>15.</td><td>EN ISO 23908:2013</td><td>Sharps injury protection — Sharps protection mechanisms for single-use needles, introducers for catheters and needles used for blood testing, monitoring, sampling and medical substance administration — Requirements and test methods</td></tr><tr><td>16.</td><td>Regulation (EC) No 1907/2006</td><td>concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)</td></tr></table>

# 10. Configuration

The verification and validation activities described in this plan are limited to SUMMED's Simject. The configurations covered in this plan are as follows.

# 10.1. Component list

<table><tr><td>Part No.</td><td>Part Name</td><td>Material</td><td>Drawing Reference</td><td>Standard Inspection Procedure</td><td>Measurement report</td></tr><tr><td>1M130AISI0010100</td><td>Syringe Collar</td><td>TPE 9066T</td><td>1M130AISI0010100 Rev.1.0</td><td>100-005-SIP-003 Rev.1.0</td><td></td></tr><tr><td>1M112AISI1010200</td><td>Syringe Carrier</td><td>PC Loxan HF1130</td><td>1M112AISI1010200 Rev.1.0</td><td>100-005-SIP-004 Rev.2.0</td><td></td></tr><tr><td>1M115AISI1040100</td><td>Needle Cower</td><td>PC-AS C1200HF</td><td>1M115AISI1040100 Rev.1.0</td><td>100-005-SIP-005 Rev.1.0</td><td></td></tr><tr><td>1M115AISI1010400</td><td>Body</td><td>PC+APS C1200HF</td><td>1M115AISI1010400 Rev.1.0</td><td>100-005-SIP-006 Rev.1.0</td><td></td></tr><tr><td>1M115AISI1040200</td><td>Body</td><td>RC+APS</td><td>1M115AISI1040200</td><td>100-005-SIP-007</td><td></td></tr></table>

<table><tr><td>Doc.No:100-005-DVP-001</td><td>version:1.0</td></tr><tr><td>Issued by:Zoey</td><td>effective date:</td></tr></table>

<table><tr><td>Part No.</td><td>Part Name</td><td>Material</td><td>Drawing Reference</td><td>Standard Inspection Procedure</td><td>Measurement report</td></tr><tr><td></td><td>Extension</td><td>C1200HIF</td><td>Rev.1.0</td><td>Rev.1.0</td><td></td></tr><tr><td>1M115AISI1040300</td><td>Cap</td><td>PC+ABS C1200HF</td><td>1M115AISI1040300 Rev.1.0</td><td>100-005-SIP-009 Rev.1.0</td><td></td></tr><tr><td>1M212AISI0050100</td><td>Steel Buckle</td><td>SUS304</td><td>1M212AISI0050100 Rev.1.0</td><td>100-005-SIP-010 Rev.1.0</td><td></td></tr><tr><td>1M112AISI1040400</td><td>Rear Cap</td><td>PC Lexan HF1130</td><td>1M112AISI1040400 Rev.1.0</td><td>100-005-SIP-011 Rev.1.0</td><td></td></tr><tr><td>1M131AISI1010800</td><td>Actuator</td><td>POM FG500P</td><td>1M131AISI1010800 Rev.1.0</td><td>100-005-SIP-012 Rev.1.0</td><td></td></tr><tr><td>1M131AISI1010900</td><td>Actuator Sleeve</td><td>POM FG500AL</td><td>1M131AISI1010900 Rev.1.0</td><td>100-005-SIP-013 Rev.1.0</td><td></td></tr><tr><td>1M131AISI1011000</td><td>Plunger Rod</td><td>POM FG500P</td><td>1M131AISI1011000 Rev.1.0</td><td>100-005-SIP-014 Rev.1.0</td><td></td></tr><tr><td>1M212AISI1011100</td><td>Plunger Rod Spring</td><td>SUS304</td><td>1M212AISI1011100 Rev.1.0</td><td>100-005-SIP-015 Rev.3.0</td><td></td></tr><tr><td>1M212AISI1011300</td><td>Needle Cover Spring</td><td>SUS304</td><td>1M212AISI1011300 Rev.1.0</td><td>100-005-SIP-016 Rev.1.0</td><td></td></tr></table>

# 10.2. Package parts

<table><tr><td>Part No.</td><td>Part Name</td><td>Material</td><td>Drawing Reference</td><td>Standard Inspection Procedure</td><td>Measurement report</td></tr><tr><td>4M81310020221</td><td>Tray (Front Sub-assembly)</td><td>PET</td><td>4M81310020221 Rev.1.0</td><td>100-005-SIP-018 Rev.1.0</td><td></td></tr><tr><td>4M81310020321</td><td>Tray(Rear Sub-assembly)</td><td>PET</td><td>4M81310020321 Rev.1.0</td><td>100-005-SIP-019 Rev.1.0</td><td></td></tr><tr><td>4M81000000216Br</td><td>Carton</td><td>Corrugated Paper</td><td>4M81000000216Br Rev.1.0</td><td>100-005-SIP-022 Rev.1.0</td><td></td></tr><tr><td>4W81130010421</td><td>Shrink Wrap</td><td>PE</td><td>4W81130010421 Rev.1.0</td><td>100-005-SIP-020 Rev.1.0</td><td></td></tr><tr><td>4M82000000317W</td><td>Expanded Polyethylene</td><td>EPE</td><td>4M82000000317W Rev.1.0</td><td>100-005-SIP-021 Rev.1.0</td><td></td></tr></table>

# 10.3. Accessory list

<table><tr><td>No.</td><td>Name</td><td>Material</td><td>Specification</td><td>Measurement report</td></tr><tr><td>1</td><td>Prefilled 
Syringe (PFS)</td><td>Glass/silicone rubber</td><td>1mL</td><td></td></tr></table>

<table><tr><td>Doc.No: 
100-005-DVP-001</td><td>version: 
1.0</td></tr><tr><td>Issued by: 
Zoey</td><td>effective date:</td></tr></table>

# 10.4. Equipment Qualification

<table><tr><td>Equipment No.</td><td>Equipment Name</td><td>Equipment Model</td><td>Status (Qualified)</td><td>Qualification Expiry Date</td><td>Qualification report</td></tr><tr><td>JS-JC-24-005</td><td>Simject Auto-Injection Pen Dedicated Tester</td><td>23089-JX-SM</td><td>Qualified</td><td>2026.05.06</td><td>DH25AX017400001DH25AX017400002DH25AX01740000320250508620067</td></tr><tr><td>JS-JC-24-015</td><td>Constant Temperature and Humidity Test Chamber</td><td>STH1040A</td><td>Qualified</td><td>2026.02.17</td><td>SZZB(S)202502180052</td></tr><tr><td>JS-JC-22-011</td><td>Hongzhan Constant Temperature and Humidity Test Chamber</td><td>PR-408</td><td>Qualified</td><td>2026.07.13</td><td>SZZB(S)202507140086</td></tr></table>

# 11. Design Verification/Validation

Design verification and validation activities should be conducted to either establish conformance with a design input requirement or to ensure the designed device meets the defined user needs and intended use(s). As required by the QSR(Quality System Regulation), SUMMED shall establish and maintain procedures for verifying/validating the device design.

The results of the design verification/validation, including identification of the design, method(s), the date, and the individual(s) performing the verification/validation, shall be documented in the Design History File (DHF).

The following tables present the verification and validation methods and activities for the SM100-005 Project.

# 11.1. Tools verification/Validation

All newly developed or modified tools shall be verified and validated to ensure they can produce products according to design specifications.

<table><tr><td>Doc.No: 
100-005-DVP-001</td><td>version: 
1.0</td></tr><tr><td>Issued by: 
Zoey</td><td>effective date:</td></tr></table>

<table><tr><td>Tool No.</td><td>Tool Name</td><td>Tool Description</td><td>Responsible Department</td><td>verification/ Validation Protocol</td><td>verification/ Validation Report</td></tr><tr><td>JS-JJ-24-022</td><td>Lisa &amp; Lucy Front Sub-assembly and PFS manual terminal assembly fixture</td><td>Fixture for manually assembling the Front Sub-assembly and PFS together</td><td>RD</td><td>000-000-FVP-001 (1.0)</td><td>TVP-JS-RD-24</td></tr><tr><td>JS-JJ-24-023</td><td>Lisa &amp; Lucy Front and rear Sub-assembly manual terminal assembly fixture</td><td>Fixture for manually assembling the Front and Rear Sub-assembly together</td><td>RD</td><td>000-000-FVP-001 (1.0)</td><td>TVP-JS-RD-24</td></tr></table>

# 11.2. Process/Testing Equipment/Machine Verification/Validation

All equipment, software, and machines used for designing and manufacturing the product shall be verified and validated to ensure they perform as intended. All processes and activities that cannot be verified through the following actions will be evaluated for necessary validation. This includes a thorough review of the design and manufacturing processes to identify any potential risks.

<table><tr><td>No.</td><td colspan="6">Process/Testing Equipment/Machine Verification/Validation Table</td></tr><tr><td rowspan="3">1</td><td>Equipment Number</td><td>肾上腺素Simject 前组件设备</td><td>Equipment Description</td><td>PYSM-TF-240924-02</td><td>Responsible Department</td><td>PD</td></tr><tr><td>IQ Protocol</td><td>EVP-JS-SC-24-010</td><td>OQ Protocol</td><td>EVP-JS-SC-24-011</td><td>PQ Protocol</td><td>EVP-JS-SC-24-012</td></tr><tr><td>IQ Report</td><td>EVR-JS-SC-24-010</td><td>OQ Report</td><td>EVR-JS-SC-24-011</td><td>PQ Report</td><td>EVR-JS-SC-24-012</td></tr><tr><td rowspan="2">2</td><td>Equipment Number</td><td>肾上腺素Simject 后组件设备</td><td>Equipment Description</td><td>PSM-RA-001</td><td>Responsible Department</td><td>PD</td></tr><tr><td>IQ Protocol</td><td>EVP-JS-SC-24-001</td><td>OQ Protocol</td><td>EVP-JS-SC-24-002</td><td>PQ Protocol</td><td>EVP-JS-SC-24-003</td></tr></table>

<table><tr><td>Doc.No: 
100-005-DVP-001</td><td>version: 
1.0</td></tr><tr><td>Issued by: 
Zoey</td><td>effective date:</td></tr></table>

<table><tr><td></td><td>IQ Report</td><td>EVR-JS-SC-24-001</td><td>OQ Report</td><td>EVR-JS-SC-24-002</td><td>PQ Report</td><td>EVR-JS-SC-24-003</td></tr><tr><td rowspan="3">3</td><td>Equipment Number</td><td>恒温恒湿箱(JS-JC-24-015)</td><td>Equipment Description</td><td>STH1040A</td><td>Responsible Department</td><td>QD</td></tr><tr><td>IQ Protocol</td><td>J202411015808 A-02</td><td>OQ Protocol</td><td>J202411015808 A-02</td><td>PQ Protocol</td><td>J202411015808A-02</td></tr><tr><td>IQ Report</td><td>J202411015808 A-02 Report</td><td>OQ Report</td><td>J202411015808 A-02 Report</td><td>PQ Report</td><td>J202411015808A-02Report</td></tr><tr><td rowspan="3">4</td><td>Equipment Number</td><td>Simject Auto-Injection Pen Dedicated Tester</td><td>Equipment Description</td><td>23089-JX-SM</td><td>Responsible Department</td><td>QD</td></tr><tr><td>IQ Protocol</td><td>EVP-JS-JC-25-001 A0</td><td>OQ Protocol</td><td>EVP-JS-JC-25-001 A0</td><td>PQ Protocol</td><td>EVP-JS-JC-25-001 A0</td></tr><tr><td>IQ Report</td><td>EVR-JS-JC-25-001 A0</td><td>OQ Report</td><td>EVR-JS-JC-25-001 A0</td><td>PQ Report</td><td>EVR-JS-JC-25-001 A0</td></tr></table>

<table><tr><td>Doc.No: 
100-005-DVP-001</td><td>version: 
1.0</td></tr><tr><td>Issued by: 
Zoey</td><td>effective date:</td></tr></table>

# 11.3. Verification/validation Test Matrix

The Test Matrix present the verification and validation test items, sample quantity, testing time and the test schedule.

<table><tr><td rowspan="2">No.</td><td rowspan="2" colspan="2">Test</td><td rowspan="2">Sample Quantity</td><td rowspan="2">Total sample quantity</td><td rowspan="2">Testing time (days)</td><td colspan="2">Schedule time</td><td colspan="2">Actual Time</td></tr><tr><td>Start</td><td>Finish</td><td>Start</td><td>Finish</td></tr><tr><td>1</td><td colspan="2">Function test</td><td>30</td><td rowspan="11">2520</td><td>10</td><td></td><td></td><td></td><td></td></tr><tr><td rowspan="6">2</td><td rowspan="6">Reliability test</td><td>Transportation</td><td>Front sub-assembly300 pcs/cartonRear sub-assembly300 pcs/carton</td><td>40</td><td></td><td></td><td></td><td></td></tr><tr><td>Cool,standarcd and warm</td><td>180</td><td>20</td><td></td><td></td><td></td><td></td></tr><tr><td>Free fall</td><td>30</td><td rowspan="4">70</td><td></td><td></td><td></td><td></td></tr><tr><td>Dry-heat</td><td>60</td><td></td><td></td><td></td><td></td></tr><tr><td>Cold-storage</td><td>60</td><td></td><td></td><td></td><td></td></tr><tr><td>Vibration</td><td>30</td><td></td><td></td><td></td><td></td></tr><tr><td rowspan="2">3</td><td rowspan="2">Stability test</td><td>Accelerated aging</td><td>180</td><td>134</td><td></td><td></td><td></td><td></td></tr><tr><td>Real time aging</td><td>1620</td><td>932</td><td></td><td></td><td></td><td></td></tr><tr><td>4</td><td colspan="2">Biocompatibility</td><td>30</td><td>60</td><td></td><td></td><td></td><td></td></tr><tr><td>5</td><td colspan="2">Markings, Labelling and IFU</td><td>/</td><td>7</td><td></td><td></td><td></td><td></td></tr></table>

<table><tr><td>Doc.No: 
100-005-DVP-001</td><td>version: 
1.0</td></tr><tr><td>Issued by: 
Zoey</td><td>effective date:</td></tr></table>

# 11.4. Design Verification/Validation Test Executive Summary

The Design Verification and Validation Test shall be conducted in accordance with the following table

<table><tr><td>No</td><td colspan="2">V/V Test items</td><td>Test Method</td><td>Test Criteria</td><td>Test protocol</td><td>Test report</td></tr><tr><td rowspan="10">1</td><td rowspan="10">Function test</td><td>Does accuracy</td><td rowspan="10">100-005-TIS-023</td><td>0.27&lt;Injection volume&lt;0.34mL</td><td></td><td></td></tr><tr><td>Needle extension length during injection: ≥0.5 in (12.70 mm)</td><td>0.6in(±0.1in)15.2 4mm(±2.54mm)</td><td></td><td></td></tr><tr><td>Cap removal force</td><td>5-35 N</td><td></td><td></td></tr><tr><td>injection activation force.</td><td>5-25 N</td><td></td><td></td></tr><tr><td>Injection time for 0.3 mL dose</td><td>≤2 seconds</td><td></td><td></td></tr><tr><td>medicinal product must be visible in the viewing window for inspection prior to use.</td><td>Clear and identifiable viewing window</td><td></td><td></td></tr><tr><td>Needle cover override force must exceed 2× the injection activation force.</td><td>&gt;50 N</td><td></td><td></td></tr><tr><td>User must be able to distinguish among unused, in-use, used, or deactivated states of the auto-injector.</td><td>Post-injection, PFS plunger visible in the window</td><td></td><td></td></tr><tr><td>Needle must remain shielded: - When the device contacts the test surface. - When the device is not in contact with the test surface.</td><td>Needle shielding mechanism</td><td></td><td></td></tr><tr><td>The NIS shall indicate by visual, audible or tactile means, or any combination of these that the delivery operation</td><td>auditory signal (≥60 dB measured at 30 cm distance)</td><td></td><td></td></tr></table>

<table><tr><td>Doc.No: 
100-005-DVP-001</td><td>version: 
1.0</td></tr><tr><td>Issued by: 
Zoey</td><td>effective date:</td></tr></table>

<table><tr><td></td><td colspan="2"></td><td>Sharps injury protection</td><td></td><td></td><td></td><td></td></tr><tr><td rowspan="12">2</td><td rowspan="12">Reliability test</td><td rowspan="10">Transportation</td><td>Schedule A Handing</td><td rowspan="9">ASTM D4169-23e1</td><td rowspan="9">The packaging is complete and undamaged</td><td></td><td></td></tr><tr><td>Schedule B Warehouse Stacking</td><td></td><td></td></tr><tr><td>Schedule C Vehicle Stacking</td><td></td><td></td></tr><tr><td>Schedule D Stacked Vibration</td><td></td><td></td></tr><tr><td>Schedule E Vehicle Vibration</td><td></td><td></td></tr><tr><td>Schedule F Loose-load Vibration</td><td></td><td></td></tr><tr><td>Schedule H Environmental Hazard</td><td></td><td></td></tr><tr><td>Schedule J Concentrated impact</td><td></td><td></td></tr><tr><td>Schedule A Handing</td><td></td><td></td></tr><tr><td>Function test</td><td>100-005-TIS-023</td><td>The injector shall still meet its basic functional requirements.</td><td></td><td></td></tr><tr><td rowspan="2">Cool,standard and warm</td><td>Preconditioning-Cool, Function test</td><td>ISO 11608.1-2022 10.2.1</td><td>The injector shall still meet its basic functional requirements.</td><td></td><td></td></tr><tr><td>Preconditioning-Standard, Function test</td><td>ISO 11608.1-2022 10.2.1</td><td>The injector shall still meet its basic functional requirements.</td><td></td><td></td></tr></table>

<table><tr><td>Doc.No: 
100-005-DVP-001</td><td>version: 
1.0</td></tr><tr><td>Issued by: 
Zoey</td><td>effective date:</td></tr></table>

<table><tr><td rowspan="5"></td><td rowspan="5"></td><td></td><td>Ppreconditioning-Warm, Function test</td><td>ISO 11608.1-2022 10.2.1</td><td>The injector shall still meet its basic functional requirements.</td><td></td><td></td></tr><tr><td>Free fall</td><td>Preconditioning-Dry-heat, Function test</td><td>ISO 11608.1-2022 10.3.1</td><td>For each test direction, no more than three distinct container ruptures shall occur, and the injector shall still meet its basic functional requirements.</td><td></td><td></td></tr><tr><td>Dry-heat</td><td>Preconditioning-cold-storage, Function test</td><td>ISO 11608.1-2022 10.3.2</td><td>The injector shall still meet its basic functional requirements.</td><td></td><td></td></tr><tr><td>Cold-storage</td><td>Preconditioning-Free fall testing , Function test</td><td>ISO 11608.1-2022 10.3.3</td><td>The injector shall still meet its basic functional requirements.</td><td></td><td></td></tr><tr><td>vibration</td><td>Preconditioning-Vibration, Function test</td><td>ISO 11608.1-2022 10.3.6</td><td>The injector shall still meet its basic functional requirements.</td><td></td><td></td></tr><tr><td rowspan="2">3</td><td rowspan="2">Stabilit y test</td><td>Accelerated aging</td><td>Accelerated aging, Function test</td><td>ASTM-F1980-2021</td><td>The injector shall still meet its basic functional requirements.</td><td></td><td></td></tr><tr><td>Real time aging</td><td>Real time aging, Function test</td><td>The injector shall maintain its primary function (shel f-life 2.5 years )</td><td>The injector shall still meet its basic functional requirements.</td><td></td><td></td></tr><tr><td>4</td><td colspan="2">Biocompatibility</td><td>Biological evaluation</td><td>ISO 10993.1-2020</td><td>/</td><td></td><td></td></tr></table>

<table><tr><td>Doc.No: 
100-005-DVP-001</td><td>version: 
1.0</td></tr><tr><td>Issued by: 
Zoey</td><td>effective date:</td></tr></table>

<table><tr><td rowspan="3"></td><td rowspan="3"></td><td>In Vitro Cytotoxicity</td><td>ISO 10993.5-2009</td><td>Cells should maintain their normal morphology, with no evident cell death or damage</td><td></td><td></td></tr><tr><td>Skin Sensitization</td><td>ISO 10993.10-2021</td><td>No significant skin reactions</td><td></td><td></td></tr><tr><td>Irritation</td><td>ISO 10993.23-2021</td><td>No significant irritation reactions</td><td></td><td></td></tr><tr><td>6</td><td>Markings, Labelling and IFU</td><td>visual inspection for Instructions for use (IFU)、marking、label</td><td>ISO 11608-1 Annex E</td><td>The content of the label and instructions for use is consistent with the requirements.</td><td></td><td></td></tr></table>

# 12. Schedule And Resources

This schedule summarizes the various verification and validation tasks and their relationship to the overall project. This is to define an orderly flow between project activities and verification and validation tasks and summarizes how the results provide feedback to the development process.

<table><tr><td>Project Phase</td><td>V/V Test</td><td>Responsible Department</td></tr><tr><td>Planning</td><td>URS/ Market Evaluation/NPR</td><td>BD/RD/PM/RA</td></tr><tr><td>Design Input</td><td>DD Plan/ DIR</td><td>RD/PM/RA</td></tr><tr><td>Design Output</td><td>Metal parts validation</td><td>RD/QC/PM</td></tr><tr><td>Design Verification and Validation</td><td>Tool validation</td><td>PD/RD</td></tr><tr><td>Design Verification and Validation</td><td>Equipment FAT/SAT and Validation</td><td>PD/QC</td></tr><tr><td>Design Verification and Validation</td><td>Assembly validation</td><td>PD/QC/RD</td></tr><tr><td>Design Verification and</td><td>Design verification and Validation Test</td><td>RD/PM</td></tr></table>

<table><tr><td>Doc.No: 
100-005-DVP-001</td><td>version: 
1.0</td></tr><tr><td>Issued by: 
Zoey</td><td>effective date:</td></tr></table>

Validation

# 13. V/VMP Plan Review

This master plan shall be reviewed by the Project Leader, R&D Engineer, QA Engineer or Manager, RA Engineer or Manager and customer representative, and be approved by the R&D Manager.